Brahmer JR - Search Results

1

Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective stud.

Voong KR, Illei PB, Presson B, Singh D, Zeng Z, Lanis M, Hales RK, Hu C, Tran PT, Georgiades C, Lin CT, Thiboutout J, Brahmer JR, Forde PM, Naidoo J, Anagnostou V, Smith KN. Voong KR, et al. Among authors: brahmer jr. J Immunother Cancer. 2023 Oct;11(10):e007188. doi: 10.1136/jitc-2023-007188. J Immunother Cancer. 2023. PMID: 37793854 Free PMC article.

2

What lies within: novel strategies in immunotherapy for non-small cell lung cancer.

Forde PM, Reiss KA, Zeidan AM, Brahmer JR. Forde PM, et al. Among authors: brahmer jr. Oncologist. 2013;18(11):1203-13. doi: 10.1634/theoncologist.2013-0171. Epub 2013 Oct 8. Oncologist. 2013. PMID: 24105749 Free PMC article. Review.

3

New strategies in lung cancer: translating immunotherapy into clinical practice.

Forde PM, Kelly RJ, Brahmer JR. Forde PM, et al. Among authors: brahmer jr. Clin Cancer Res. 2014 Mar 1;20(5):1067-73. doi: 10.1158/1078-0432.CCR-13-0731. Epub 2014 Jan 27. Clin Cancer Res. 2014. PMID: 24470514 Review.

4

Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief report.

Forde PM, Hooker CM, Boikos SA, Petrini I, Giaccone G, Rudin CM, Yang SC, Illei PB, Hann CL, Ettinger DS, Brahmer JR, Kelly RJ. Forde PM, et al. Among authors: brahmer jr. J Thorac Oncol. 2014 Mar;9(3):414-8. doi: 10.1097/JTO.0000000000000065. J Thorac Oncol. 2014. PMID: 24518093 Free PMC article.

5

New strategies in lung cancer: epigenetic therapy for non-small cell lung cancer.

Forde PM, Brahmer JR, Kelly RJ. Forde PM, et al. Among authors: brahmer jr. Clin Cancer Res. 2014 May 1;20(9):2244-8. doi: 10.1158/1078-0432.CCR-13-2088. Epub 2014 Mar 18. Clin Cancer Res. 2014. PMID: 24644000 Free PMC article. Review.

6

Harnessing the power of the immune system via blockade of PD-1 and PD-L1: a promising new anticancer strategy.

Reiss KA, Forde PM, Brahmer JR. Reiss KA, et al. Among authors: brahmer jr. Immunotherapy. 2014;6(4):459-75. doi: 10.2217/imt.14.9. Immunotherapy. 2014. PMID: 24815784 Free PMC article. Review.

7

Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer.

Anagnostou VK, Brahmer JR. Anagnostou VK, et al. Among authors: brahmer jr. Clin Cancer Res. 2015 Mar 1;21(5):976-84. doi: 10.1158/1078-0432.CCR-14-1187. Clin Cancer Res. 2015. PMID: 25733707 Review.

8

Heterogeneity of resistance mutations detectable by nextgeneration sequencing in TKI-treated lung adenocarcinoma.

Belchis DA, Tseng LH, Gniadek T, Haley L, Lokhandwala P, Illei P, Gocke CD, Forde P, Brahmer J, Askin FB, Eshleman JR, Lin MT. Belchis DA, et al. Among authors: brahmer j. Oncotarget. 2016 Jul 19;7(29):45237-45248. doi: 10.18632/oncotarget.9931. Oncotarget. 2016. PMID: 27304188 Free PMC article.

9

Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.

Cappelli LC, Gutierrez AK, Baer AN, Albayda J, Manno RL, Haque U, Lipson EJ, Bleich KB, Shah AA, Naidoo J, Brahmer JR, Le D, Bingham CO 3rd. Cappelli LC, et al. Among authors: brahmer jr. Ann Rheum Dis. 2017 Jan;76(1):43-50. doi: 10.1136/annrheumdis-2016-209595. Epub 2016 Jun 15. Ann Rheum Dis. 2017. PMID: 27307501 Free PMC article.

10

Immunotherapy for Lung Cancer: No Longer an Abstract Concept.

Marrone KA, Naidoo J, Brahmer JR. Marrone KA, et al. Among authors: brahmer jr. Semin Respir Crit Care Med. 2016 Oct;37(5):771-782. doi: 10.1055/s-0036-1592298. Epub 2016 Oct 12. Semin Respir Crit Care Med. 2016. PMID: 27732998 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240 results

Search Page